USFDA clears Lupin's Goa facility; stocks up 6.25%
Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.
Jul 07, 2016, 17:08 PM ISTCommitted to close corrective action at Goa by Dec: Lupin
New Delhi: Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December.
Jun 13, 2016, 16:07 PM IST